@article{ada4e922504142bb9e88854b4fff333e,
title = "The Role of Potentially Modifiable Factors in a Standard Work Protocol to Decrease Complications in Adult Spinal Deformity Surgery: A Systematic Review, Part 1",
abstract = "Study Design: Structured Literature Review. Objectives: We sought to evaluate the peer-reviewed literature for potentially modifiable patient and surgical factors that could be incorporated into a Standard Work protocol to decrease complications in adult spinal deformity (ASD) surgery. Summary of Background Data: Lean Methodology uses Standard Work to improve efficiency and decrease waste and error. ASD is known to have a high surgical complication rate. Several patient and surgical potentially modifiable factors have been suggested to affect complications, including preoperative hemoglobin, bone density, body mass index (BMI), age-appropriate realignment, preoperative albumin/prealbumin, and smoking status. We sought to evaluate the literature for evidence supporting these factors to include in a Standard Work protocol to decrease complications. Methods: Each of these six factors was developed into an appropriate clinical question that included the patient population, surgical intervention, a comparison group, and outcomes measure (PICO question). A comprehensive literature search was then performed. The authors reviewed abstracts and analyzed data from included studies. From 456 initial citations with abstract, 173 articles underwent full-text review. The best available evidence for clinical questions regarding the influence of these factors was provided by 93 included studies. Results: We found fair evidence supporting a low preoperative hemoglobin level associated with increased transfusion rates and decreased BMD and increased BMI associated with increased complication rates. Fair evidence supported low albumin/prealbumin associated with increased complications. There was fair evidence associating smoking exposure to increased reoperations, but conflicting evidence associating it with increased complications. There was no evidence in the literature evaluating age-appropriate realignment and complications. Conclusion: Preoperative hemoglobin, bone density, body mass index, preoperative albumin/prealbumin, and smoking status all are potentially modifiable risk factors that are associated with increased complications in the adult spine surgery population. Developing a Standard Work Protocol for patient evaluation and optimization should include these factors. Level of Evidence: Level II.",
keywords = "Adult spinal deformity surgery, Lean",
author = "Burton, {Douglas C.} and Sethi, {Rajiv K.} and Wright, {Anna K.} and Daniels, {Alan H.} and Ames, {Christopher P.} and Reid, {Daniel B.} and Klineberg, {Eric O.} and Robert Harper and Mundis, {Gregory M.} and Hlubek, {Randall J.} and Shay Bess and Hart, {Robert A.} and Kelly, {Michael P.} and Lenke, {Lawrence G.}",
note = "Funding Information: Author disclosures: DCB (grants from Orthofix, during the conduct of the study; personal fees from DePuy and Allosource; grants from DePuy and Pfizer, outside the submitted work), RKS (none), AKW (none), AHD (grants and personal fees from Orthofix; personal fees from Stryker, EOS, and Spineart; other from Springer, outside the submitted work), CPA (personal fees from UCSF, Stryker, Biomet Zimmer Spine, DePuy Synthes, NuVasive, K2M, Medicrea, Medtronic, Biomet Zimmer, Titan Spine, International Spine Study Group [ISSG], Operative Neurosurgery, Scoliosis Research Society [SRS], and Global Spinal Analytics, outside the submitted work), DBR (none), EOK (personal fees from DePuy Synthes, Stryker, K2M, Springer, Trevena, and Allosource; grants and personal fees from AO Spine; personal fees from Medicrea, outside the submitted work), RH (none), GMM (personal fees from NuVasive, K2M, Allosource, Viseon, and SeaSpine, outside the submitted work; in addition, GMM has a patent NuVasive with royalties paid, and a patent K2M with royalties paid), RJH (none), SB (grants from NuVasive, Medtronic, Stryker Spine, Biomet Spine, and Orthofix; personal fees from K2 Medical, outside the submitted work), RAH (personal fees from Globus, Seaspine, and DePuy Synthes; grants from ISSGF; personal fees from Medtronic and Orthofix, outside the submitted work), MPK (grants from DePuy/Synthes Spine and AOSpine, outside the submitted work; in addition, MPK has a patent Pharmaceuticals pending), LGL (personal fees from Medtronic; grants and personal fees from DePuy-Synthes Spine; personal fees from K2M, Fox Rothschild, LLC, and Quality Medical Publishing; nonfinancial support from Broadwater, Seattle Science Foundation, Stryker Spine, and The Spinal Research Foundation; grants and nonfinancial support from Scoliosis Research Society and AOSpine; grants from EOS, Setting Scoliosis Straight Foundation; other from Evans Family Donation, Fox Family Foundation, outside the submitted work). Publisher Copyright: {\textcopyright} 2019 Scoliosis Research Society",
year = "2019",
month = sep,
doi = "10.1016/j.jspd.2019.04.003",
language = "English (US)",
volume = "7",
pages = "669--683",
journal = "Spine Deformity",
issn = "2212-134X",
publisher = "Elsevier BV",
number = "5",
}